arrow
Q

Qi Wang

Department of Oncology
H指数:29
被引数:4,130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination Surface Targeting Strategies in Relapsed Small Cell Lung Cancer (SCLC) to Overcome Intratumoral Heterogeneity Associated with Treatment Resistance

在复发小细胞肺癌(SCLC)中结合表面靶向策略以克服与治疗耐药性相关的肿瘤内异质性

2025-08-290
PRE
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis

Stapokibart在特应性皮炎患者中延长给药间隔的疗效与安全性

2025-07-230
PRE
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

利用局部和系统性免疫特征分析,区分广泛期小细胞肺癌中接受一线信迪利单抗(anti-PD-1抗体)联合化疗的不同应答者:一项Ⅱ期研究的探索性生物标志物分析

2025-05-230
OA
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study

沙利度胺为基础的方案在大型颗粒淋巴细胞白血病中显示出有希望的疗效:一项多中心II期研究

2025-03-121
OA
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets
2024-02-014
OA